Cassin
Senior Member
- Reaction score
- 78
Well it seems American Crew Copper-Peptides are selling so well, grocery stores are now selling them. At least in Dallas....in Albertsons. Extremely cheap too. Normaly you have to shell out $20 to $30 for the 6oz bottle. I just saw it at Albertsons for $11.99 (yes the 6oz bottle). Too bad I just dropped $50 F-ING bucks for a 6oz bottle of Tricomin.......DAMN
Here is a write up about American Crew CP's
************************************************
FOR IMMEDIATE RELEASE
June 28, 2001
8:30 AM (EDT)
ProCyte Contact:
Jack Clifford, Chairman/CEO
(425) 869-1239
http://www.procyte.com
PROCYTE AND AMERICAN CREW IN DISTRIBUTION AGREEMENT
Deal introduces Copper Peptide Technology to the Salon and Spa Markets
REDMOND, WA  June 28, 2001? ProCyte Corporation (OTC BB: PRCY), a leading medical skin and hair care company, today announced long term license and supply agreements with American Crew, a division of The Colomer Group, for use of its patented AHK Copper Peptide Complex for hair care products for sale in the hair and beauty salon and day spa marketplaces. The agreements cover the United States and certain international markets and provide ProCyte with milestone and royalty payments that include minimum payment levels.
American Crew is a leader in meeting the needs of professional salons. Their products are specifically formulated for men and are sold in 35,000 salons in the U.S. and over 40 countries around the world.
The retail market for salon hair care products, including the newly introduced thinning hair category market channels, was in excess of $4 billion in the United States. It is a rapidly growing market segment with over 60 million men and women affected by thinning hair as part of the aging process.
The product will target women and men with thinning hair. ProCyte currently markets a line of hair care products to dermatologists, plastic and cosmetic surgeons under the brand name Tricomin® (http://www.tricomin.com).
"We are excited to be able to make our proven Copper Peptide technology available to the professional salon market with a well positioned partner such as American Crew." said Jack Clifford, ProCyte Chairman and CEO. "ProCyte has established a growing position in the medical hair transplant marketplace, where our Copper Peptide wound care products have proven success in getting hair grafts off to rapid recovery. ProCyte’s Triamino Copper Complex™ Tricomin® line of thinning hair care products have been a popular follow-on treatment."
American Crew manufactures, develops and internationally markets high quality grooming products for men, sold exclusively in professional salons. A leader in men’s fashion and grooming products, the American Crew brand includes a complete line of shampoos, conditioners, styling, finishing, shaving, skin, body, fragrance and hair care products. American Crew also sells the Modern Organic Products and D:FI hair brands for women as well as men.
About ProCyte:
ProCyte Corporation is a healthcare products company that develops and markets products for skin health, hair care and wound care. The Company’s comprehensive therapeutic and anti-aging skin care lines include products for post-procedure treatments and anti-aging applications, as well as products for thinning hair. Many products incorporate the ProCyte patented, clinically proven Copper Peptide technology, which is marketed directly to dermatologists and cosmetic physicians through the Company’s own sales force and through distribution partners and licensees for wound care and consumer market segments.
This release contains forward-looking statements relating to the research, development, commercialization, production, marketing and distribution of the Company's products and future operating results that are subject to certain risks and uncertainties which could cause actual results to differ materially from those projected. The words "believe," "expect," "intend," "anticipate," variations of such words, and similar expressions identify forward-looking statements, but their absence does not mean that the statement is not forward-looking. These statements are not guarantees of future performance and are subject to certain risks, uncertainties and assumptions that are difficult to predict. Factors that could affect the Company’s actual results include its ability to develop, commercialize and produce new products, the market acceptance of existing and potential future products, the availability, cost and timely delivery of materials and services from and performance of third party suppliers, manufacturers, distributors, licensees and other collaborative partners, the satisfaction of regulatory requirements, and the receipt, timing, terms and conditions of required regulatory approvals. Reference is made to the Company’s latest Quarterly Report on Form 10 – Q filed with the Securities and Exchange Commission for a more detailed description of such factors. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this release. The Company undertakes no obligation to publicly update any forward-looking statement to reflect new information, events or circumstances after the date of this release or to reflect the occurrence of unanticipated events.
Here is a write up about American Crew CP's
************************************************
FOR IMMEDIATE RELEASE
June 28, 2001
8:30 AM (EDT)
ProCyte Contact:
Jack Clifford, Chairman/CEO
(425) 869-1239
http://www.procyte.com
PROCYTE AND AMERICAN CREW IN DISTRIBUTION AGREEMENT
Deal introduces Copper Peptide Technology to the Salon and Spa Markets
REDMOND, WA  June 28, 2001? ProCyte Corporation (OTC BB: PRCY), a leading medical skin and hair care company, today announced long term license and supply agreements with American Crew, a division of The Colomer Group, for use of its patented AHK Copper Peptide Complex for hair care products for sale in the hair and beauty salon and day spa marketplaces. The agreements cover the United States and certain international markets and provide ProCyte with milestone and royalty payments that include minimum payment levels.
American Crew is a leader in meeting the needs of professional salons. Their products are specifically formulated for men and are sold in 35,000 salons in the U.S. and over 40 countries around the world.
The retail market for salon hair care products, including the newly introduced thinning hair category market channels, was in excess of $4 billion in the United States. It is a rapidly growing market segment with over 60 million men and women affected by thinning hair as part of the aging process.
The product will target women and men with thinning hair. ProCyte currently markets a line of hair care products to dermatologists, plastic and cosmetic surgeons under the brand name Tricomin® (http://www.tricomin.com).
"We are excited to be able to make our proven Copper Peptide technology available to the professional salon market with a well positioned partner such as American Crew." said Jack Clifford, ProCyte Chairman and CEO. "ProCyte has established a growing position in the medical hair transplant marketplace, where our Copper Peptide wound care products have proven success in getting hair grafts off to rapid recovery. ProCyte’s Triamino Copper Complex™ Tricomin® line of thinning hair care products have been a popular follow-on treatment."
American Crew manufactures, develops and internationally markets high quality grooming products for men, sold exclusively in professional salons. A leader in men’s fashion and grooming products, the American Crew brand includes a complete line of shampoos, conditioners, styling, finishing, shaving, skin, body, fragrance and hair care products. American Crew also sells the Modern Organic Products and D:FI hair brands for women as well as men.
About ProCyte:
ProCyte Corporation is a healthcare products company that develops and markets products for skin health, hair care and wound care. The Company’s comprehensive therapeutic and anti-aging skin care lines include products for post-procedure treatments and anti-aging applications, as well as products for thinning hair. Many products incorporate the ProCyte patented, clinically proven Copper Peptide technology, which is marketed directly to dermatologists and cosmetic physicians through the Company’s own sales force and through distribution partners and licensees for wound care and consumer market segments.
This release contains forward-looking statements relating to the research, development, commercialization, production, marketing and distribution of the Company's products and future operating results that are subject to certain risks and uncertainties which could cause actual results to differ materially from those projected. The words "believe," "expect," "intend," "anticipate," variations of such words, and similar expressions identify forward-looking statements, but their absence does not mean that the statement is not forward-looking. These statements are not guarantees of future performance and are subject to certain risks, uncertainties and assumptions that are difficult to predict. Factors that could affect the Company’s actual results include its ability to develop, commercialize and produce new products, the market acceptance of existing and potential future products, the availability, cost and timely delivery of materials and services from and performance of third party suppliers, manufacturers, distributors, licensees and other collaborative partners, the satisfaction of regulatory requirements, and the receipt, timing, terms and conditions of required regulatory approvals. Reference is made to the Company’s latest Quarterly Report on Form 10 – Q filed with the Securities and Exchange Commission for a more detailed description of such factors. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this release. The Company undertakes no obligation to publicly update any forward-looking statement to reflect new information, events or circumstances after the date of this release or to reflect the occurrence of unanticipated events.
